How much does a box of Bosutinib cost?

Bosutinib/Bosutinib (Bosutinib), as a targeted anti-cancer drug, its greatest benefit lies in its high efficiency, precision and relatively mild therapeutic properties. It can specifically inhibit the abnormal BCR-ABL protein activity in chronic myelogenous leukemia (CML) and control the progression of the disease from the root. Compared with traditional chemotherapy, Bosutinib does not extensively kill normal cells, so it has milder side effects, better tolerance, and significantly improves patients' quality of life.

From a clinical application perspective, the most prominent advantage of bosutinib is its therapeutic potential for drug-resistant leukemia. Many CML patients who take imatinib for a long time will have reduced efficacy due to genetic mutations. Bosutinib can overcome multiple mutations and restore anti-cancer activity.

Bosutinib can also induce hematological and cytogenetic remission quickly. Generally, a decrease in white blood cell count and a return to normal of bone marrow cells can be observed within a few weeks of treatment. Its role is not only limited to inhibiting cancer cell proliferation, but also improving the patient's overall immune status, providing a basis for long-term management. Therefore, it is regarded as a long-term control targeted drug that can "survive with disease".

Regarding price, the original drug of bosutinib is produced by Pfizer, and the original drug has not yet been officially launched in mainland China. In the international market, Swiss, Turkish and European versions are already sold. According to public data from overseas pharmacies in 2025, the Turkish version of Bosulif 500mg × 28 tablets is priced at about RMB 2,000, while the price of the Swiss or European version is close to RMB 40,000. These prices may vary slightly due to exchange rate fluctuations and channel differences.

At the same time, there are also more affordable imitation versions overseas. For example, some pharmaceutical companies in India produce bosutinib generics, which have the same ingredients as the original drug. The specifications are 100 mg × 120 tablets and the price is about RMB 1,000 to 1,500 yuan. The emergence of generic drugs has greatly improved the accessibility of drugs, especially for patients undergoing long-term treatment, and the economic burden has been significantly reduced.

Reference materials:https://go.drugbank.com/drugs/DB06616